The FDA has approved Generex Biotechnology Corp.’s drug candidate Generex Oral-lyn for experimental use in diabetic patients with dangerous illnesses who don"t have a satisfactory treatment. In order for such drugs to be given experimental approval they must demonstrate a prospect of efficacy and this drug treats diabetes by being delivered through the lining of the mouth.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지